Xi Gu1 article listing Xi Gu in Nature Communications, indexed by Paperzzz from Crossref and OSF.Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial Nature Communications